Related Experiment Video
Updated: Oct 12, 2025

Reverse Yeast Two-hybrid System to Identify Mammalian Nuclear Receptor Residues that Interact with Ligands and/or Antagonists
Published on: November 15, 2013
Inhibition of XPO-1 Mediated Nuclear Export through the Michael-Acceptor Character of Chalcones
Marta Gargantilla1, José López-Fernández1, Maria-Jose Camarasa1
1Instituto de Química Médica (IQM, CSIC) c/Juan de la Cierva 3, 28006 Madrid, Spain.
Abstract:
The nuclear export receptor exportin-1 (XPO1, CRM1) mediates the nuclear export of proteins that contain a leucine-rich nuclear export signal (NES) towards the cytoplasm. XPO1 is considered a relevant target in different human diseases, particularly in hematological malignancies, tumor resistance, inflammation, neurodegeneration and viral infections. Thus, its pharmacological inhibition is of significant therapeutic interest. The best inhibitors described so far (leptomycin B and SINE compounds) interact with XPO1 through a covalent interaction with Cys528 located in the NES-binding cleft of XPO1. Based on the well-established feature of chalcone derivatives to react with thiol groups via hetero-Michael addition reactions, we have synthesized two series of chalcones. Their capacity to react with thiol groups was tested by incubation with GSH to afford the hetero-Michael adducts that evolved backwards to the initial chalcone through a retro-Michael reaction, supporting that the covalent interaction with thiols could be reversible. The chalcone derivatives were evaluated in antiproliferative assays against a panel of cancer cell lines and as XPO1 inhibitors, and a good correlation was observed with the results obtained in both assays. Moreover, no inhibition of the cargo export was observed when the two prototype chalcones 9 and 10 were tested against a XPO1-mutated Jurkat cell line (XPO1C528S), highlighting the importance of the Cys at the NES-binding cleft for inhibition. Finally, their interaction at the molecular level at the NES-binding cleft was studied by applying the computational tool CovDock.
Insights
Chalcone derivatives were synthesized and evaluated as reversible covalent inhibitors of exportin-1 (XPO1). These compounds show antiproliferative activity, targeting XPO1
Area of Science:
- Medicinal Chemistry
- Molecular Biology
- Pharmacology
Background:
- Exportin-1 (XPO1, also known as CRM1) is a nuclear export receptor crucial for transporting proteins with leucine-rich nuclear export signals (NES) out of the nucleus.
- XPO1 is implicated in various diseases, including hematological malignancies, cancer drug resistance, inflammation, neurodegeneration, and viral infections, making it a significant therapeutic target.
- Current XPO1 inhibitors, like leptomycin B and SINE compounds, exert their effect through covalent interaction with Cys528 in the XPO1 NES-binding cleft.
Purpose of the Study:
- To synthesize and characterize novel chalcone derivatives as potential reversible covalent inhibitors of XPO1.
- To investigate the antiproliferative effects of these chalcones in cancer cell lines and their correlation with XPO1 inhibition.
- To elucidate the molecular mechanism of inhibition, focusing on the role of Cys528 in the XPO1 NES-binding cleft.
Main Methods:
- Synthesis of two series of chalcone derivatives designed to react with thiol groups.
- Assessment of thiol reactivity using glutathione (GSH) and analysis of adduct stability (reversible hetero-Michael addition).
- Evaluation of antiproliferative activity against a panel of cancer cell lines and direct XPO1 inhibition assays.
- Testing against a Cys528-mutated XPO1 Jurkat cell line (XPO1C528S) to confirm the target.
- Molecular modeling using the CovDock computational tool to study interactions within the XPO1 NES-binding cleft.
Main Results:
- Chalcones formed reversible hetero-Michael adducts with GSH, indicating potential for reversible covalent binding.
- A strong correlation was observed between the antiproliferative activity of chalcone derivatives and their efficacy as XPO1 inhibitors.
- Prototype chalcones 9 and 10 did not inhibit cargo export in XPO1C528S cells, confirming Cys528 as the critical target residue.
- Computational studies provided insights into the molecular interactions of chalcones within the XPO1 NES-binding cleft.
Conclusions:
- Chalcone derivatives represent a promising class of reversible covalent inhibitors targeting XPO1.
- The observed antiproliferative effects are directly linked to the inhibition of XPO1, specifically through interaction with Cys528.
- These findings support the therapeutic potential of chalcone-based XPO1 inhibitors for various diseases.
Related Concept Videos
Regulation of Nuclear Protein Sorting
Nuclear Export
NES are of three types- the canonical 10-residue long leucine-rich signal and other...
Inheritance of Chromatin Structures
Conjugate Addition of Enolates: Michael Addition

